About CIZUMAB
"CIZUMAB" belongs to Anti Neoplastics therapy of Oncology Division and it is available in 2 forms : Cizumab 100Mg 4Ml Injection and Cizumab 400Mg Injection.
(Read More)
Cizumab is an anticancer drug which contains Bevacizumab as composition, it is the first bevacizumab biosimilar in Indian market launched by Hetero exhibiting its strength of R&D in biotherapeutics space. It belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Cizumab 100Mg 4Ml Injection and Cizumab 400Mg Injection.
